Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 118

Pinterest proceeds to IPO stage

Rakuten is among the investors in line for an exit following Pinterest’s decision to file confidentially for an initial public offering expected to value it at more than $12bn in the next four months.

Feb 22, 2019

Ucommune seeks home in public markets

The workspace operator is reportedly seeking a $3bn valuation in a US IPO that would allow a host of corporates including several real estate developers to exit.

Feb 21, 2019

SoYoung looks to mature with $300m IPO

Tencent is in line for an exit after China-based cosmetic surgery booking platform SoYoung confidentially filed to go public in the US in an offering that could raise $300m.

Feb 20, 2019

Stealth Bio shifts to $78m IPO

Nan Fung-backed mitochondrial therapy developer Stealth BioTherapeutics floated at the foot of its range to raise $78m, having disclosed $100m in financing last June.

Feb 19, 2019

Douyu cues up $500m IPO

Tencent-backed Douyu has confidentially filed to go public in the US, following another Chinese livestreaming platform, Huya, which floated last year.

Feb 14, 2019

Peloton begins IPO cycle

Comcast and Grace Beauty-backed interactive exercise platform Peloton Interactive is interviewing banks for an offering slated for the second half of 2019.

Feb 13, 2019

Harpoon snags public markets listing

The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.

Feb 11, 2019

Stealth to make stock market appearance

Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.

Feb 11, 2019

Choi chosen to head investment at Netmarble

Netmarble’s head of corporate strategy and senior vice-president, Chanseok Choi, has been promoted to managing director and head of investment.

Feb 8, 2019

Alector achieves $176m IPO

The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.

Feb 7, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here